BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38493731)

  • 1. Design, synthesis and biological evaluation of Nrf2 modulators for the treatment of glioblastoma multiforme.
    Yang H; Song P; Li B; Li S; Yang J
    Bioorg Med Chem; 2024 Apr; 103():117684. PubMed ID: 38493731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
    Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
    Zhang L; Wang H
    Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
    Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
    Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17β-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma.
    Lin HY; Liao KH; Ko CY; Chen GY; Hsu SP; Hung CY; Hsu TI
    Free Radic Biol Med; 2021 Aug; 172():430-440. PubMed ID: 34186205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells.
    Cong ZX; Wang HD; Zhou Y; Wang JW; Pan H; Zhang DD; Zhang L; Zhu L
    J Neurooncol; 2014 Jan; 116(1):41-8. PubMed ID: 24078215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.
    Chuang HY; Hsu LY; Pan CM; Pikatan NW; Yadav VK; Fong IH; Chen CH; Yeh CT; Chiu SC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIR99AHG/miR-204-5p/TXNIP/Nrf2/ARE Signaling Pathway Decreases Glioblastoma Temozolomide Sensitivity.
    Zhou L; Ma J
    Neurotox Res; 2022 Oct; 40(5):1152-1162. PubMed ID: 35904670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isofuranodiene synergizes with temozolomide in inducing glioma cells death.
    Brunetti A; Marinelli O; Morelli MB; Iannarelli R; Amantini C; Russotti D; Santoni G; Maggi F; Nabissi M
    Phytomedicine; 2019 Jan; 52():51-59. PubMed ID: 30599912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells.
    Sun Y; Zhang X
    Anat Rec (Hoboken); 2019 Nov; 302(11):1950-1957. PubMed ID: 31177611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase.
    Gao Y; Fotovati A; Lee C; Wang M; Cote G; Guns E; Toyota B; Faury D; Jabado N; Dunn SE
    Mol Cancer Ther; 2009 Dec; 8(12):3276-84. PubMed ID: 19996271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
    Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
    Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model.
    Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD
    Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
    Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
    Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.